CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A RANDOMIZED, OPEN-LABEL, MULTI-CENTER PHASE II STUDY TO COMPARE BEVACIZUMAB PLUS SORAFENIB VERSUS SORAFENIB FOR THE THIRD-LINE TREATMENT OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (NCT02330783) 会议论文
作者:  Guo, Jun;  Sheng, Xinan;  Chi, Zhihong;  Cui, Chuanliang;  Si, Lu
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/19
A randomized, open-label, multi-center phase II study to compare bevacizumab plus sorafenib versus sorafenib for the third-line treatment of patients with metastatic renal cell carcinoma (NCT02330783) 会议论文
作者:  Guo, Jun;  Sheng, Xi Nan;  Chi, Zhihong;  Cui, Chuanliang;  Si, Lu
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace